Published online April 1, 2008
PEDIATRICS Vol. 121 No. 4 April 2008, pp. e1016-e1031 (doi:10.1542/10.1542/peds.2008-0160)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

POLICY STATEMENT

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007–2008

Committee on Infectious Diseases

The American Academy of Pediatrics recommends annual influenza immunization for all children with high-risk conditions who are 6 months of age and older, for all healthy children ages 6 through 59 months, for all household contacts and out-of-home caregivers of children with high-risk conditions and of healthy children younger than 5 years, and for all health care professionals.

To more fully protect against the morbidity and mortality of influenza, increased efforts are needed to identify and immunize all children at high risk and all healthy children ages 6 through 59 months and to inform their parents when annual immunizations are due. Previously unimmunized children who are at least 6 months of age but younger than 9 years should receive 2 doses of influenza vaccine, given 1 month apart, beginning as soon as possible on the basis of local availability during the influenza season. If children in this cohort received only 1 dose for the first time in the previous season, it is recommended that 2 doses be administered in the current season. This recommendation applies only to the influenza season that follows the first year that a child younger than 9 years receives influenza vaccine. A child who then also fails to receive 2 doses the next year should be given only 1 dose per year from that point on. Influenza vaccine should also continue to be offered throughout the influenza season, even after influenza activity has been documented in a community.

On the basis of global surveillance of circulating virus strains, the influenza vaccine may change from year to year; indeed, 1 of the 3 strains in the 2007–2008 vaccine is different from the previous year's vaccine. All health care professionals, influenza campaign organizers, and public health agencies should develop plans for expanding outreach and infrastructure to immunize all children for whom influenza vaccine is recommended. Appropriate prioritization of administering influenza vaccine will also be necessary when vaccine supplies are delayed or limited. Because the influenza season often extends into March, immunization against influenza is recommended to continue through late winter and early spring. Lastly, it is recommended that for the 2007–2008 season, and likely beyond, health care professionals do not prescribe amantadine or rimantadine for influenza treatment or chemoprophylaxis, because widespread resistance to these antiviral medications now exists among influenza A viral strains. However, oseltamivir and zanamivir can be prescribed for treatment or chemoprophylaxis, because influenza A and B strains remain susceptible.

Key Words: influenza • immunization • live-attenuated influenza vaccine • trivalent inactivated influenza vaccine • vaccine • children • pediatrics

Abbreviations: AAP—American Academy of Pediatrics • CDC—Centers for Disease Control and Prevention • LAIV—live-attenuated influenza vaccine • TIV—trivalent inactivated influenza vaccine • ILI—influenza-like illness • HAI—hemagglutinin-inhibition • GBS—Guillain-Barré syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

The following policy statement is a revision:

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2008-2009

Pediatrics 122: 1135-1141. [Full Text]

The following policy statement has been revised:

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006-2007

Pediatrics 119: 846-851. [Full Text]



This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
M. A. Allison, M. F. Daley, J. Barrow, L. A. Crane, B. L. Beaty, N. Allred, and A. Kempe
High Influenza Vaccination Coverage in Children With High-Risk Conditions During a Vaccine Shortage
Arch Pediatr Adolesc Med, May 1, 2009; 163(5): 426 - 431.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
C. Li and M. Freedman
Seasonal Influenza: An Overview
The Journal of School Nursing, February 1, 2009; 25(1_suppl): 4S - 12S.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

please modify table of contraindications
Emily Jane Woo, MD, MPH
Pediatrics Online, 2 Apr 2008 [Full text]